Response Evaluation of Newly Diagnosed EGFR Mutated NSCLC in Tertiary Referral Cancer Center in Jakarta-Indonesia

被引：0
|
作者：
Amelia, D. A. R. [1 ]
Irawan, C. [1 ]
Rajabto, W. [1 ]
Kurniawan, A. [1 ,2 ]
Sari, C. [1 ]
Nasution, M. A. [1 ]
Djatnika, D. [1 ]
Priantono, D. [1 ]
Ariyanti, F. [1 ]
Wisman, B. A. [1 ]
Purlikasari, N. P. [1 ]
Dharmaraja, F. [2 ]
Nathalia, C. [2 ]
机构：
[1] Univ Indonesia, Fac Med, Jakarta, Indonesia
[2] Univ Pelita Harapan, Fac Med, Tangerang, Indonesia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
non-small cell lung cancer; EGFR mutation; targeted therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-69
引用
收藏
页码：S669 / S669
页数：1
相关论文
共 50 条
  • [41] EPIDEMIOLOGICAL STUDY TO EVALUATE THE PREVALENCE OF EGFR MUTATIONS IN PATIENTS WITH NEWLY DIAGNOSED LOCALLY ADVANCED OR METASTATIC NSCLC (STAGE IIIB/IV NON-SMALL CELL LUNG CANCER): SPANISH REASON
    Massuti, Bartomeu
    Esteban Gonzalez, Emilo
    Majem, Margarita
    Martinez Aguillo, M. Teresa
    Martinez Banaclocha, Natividad
    Marti Blanco, Cristina
    Domine, Manuel
    Gomez-Aldaravi, Lorenzo
    Juan Vidal, Oscar
    Gonzalez-Arenas, Carmen
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S329 - S330
  • [42] Role of late response evaluation in Non Small Cell Lung Cancer (NSCLC) treated with EGFR Tyrosine Kinase Inhibitor with PET quantitative parameters
    Bhoil, A.
    Mittal, B.
    Singh, N.
    Singh, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S307 - S308
  • [43] Evaluation of morphology, HER2 status and its clinical and prognostic correlation in advanced gastric cancer: A prospective study at a tertiary referral center in Lebanon
    Deborah, Mukherji
    Miza, Salim Hammoud
    Maya, Charafeddine
    Sally, Temraz
    Ali, Shamseddine
    ANNALS OF ONCOLOGY, 2017, 28
  • [44] Bevacizumab (Bv) in non small cell lung cancer (NSCLC) patients ≥75 years old with pre-existing cardiovascular disease (CVD): Experience at a tertiary referral center.
    Strimpakos, Alexios S.
    Vassos, Demetrios
    Panagiotarakou, Meropi
    Syrigos, Konstantinos N.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Free circulating DNA by RT-PCR as predictor for chemotherapy response in newly diagnosed patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Santos, E. S.
    Talebi, T. N.
    Raez, L. E.
    Quintero, C. A.
    Walker, G.
    Farias, M.
    Ramachandran, K.
    Gordian, E.
    Gomez, J.
    Singal, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Defining the chemotherapy (CT) response in well-differentiated (WD) and dedifferentiated (DD) liposarcomas (LPS) of the retroperitoneum (RP): A tertiary referral cancer center experience.
    Somaiah, Neeta
    Gomes, Diogo Bugano Diniz
    Madewell, John E.
    Wang, Wei-Lien
    Conley, Anthony Paul
    Ravi, Vinod
    Araujo, Dejka M.
    Ludwig, Joseph A.
    Benjamin, Robert S.
    Patel, Shreyaskumar
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] A dose exploration study of almonertinib for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) patients with newly diagnosed or recurrent brain/leptomeningeal metastasis (ARTISTRY)
    Wang, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1038 - S1038
  • [48] CHEMOTHERAPY RESPONSE SCORING (CRS) FROM MULTIPLE SITES DURING INTERVAL DEBULKING SURGERY IN OVARIAN CANCER: EXPERIENCE FROM A TERTIARY REFERRAL CENTER IN EASTERN INDIA
    Midha, D.
    Lucksom, P.
    Bhaumik, J.
    Mukhopadhyay, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 244 - 244
  • [49] Optimizing Postoperative Adjuvant Therapy in Elderly Patients with Newly Diagnosed Glioblastoma: Single-Institution Audit of Clinical Outcomes from a Tertiary-Care Comprehensive Cancer Center in India
    Chatterjee, Abhishek
    Bhadane, Manish
    Manjali, Jifmi Jose
    Dasgupta, Archya
    Epari, Sridhar
    Sahay, Ayushi
    Patil, Vijay
    Moiyadi, Aliasgar
    Shetty, Prakash
    Gupta, Tejpal
    WORLD NEUROSURGERY, 2022, 161 : E587 - E595
  • [50] Clinical Implications of the T790M Mutation in Disease Characteristics and Treatment Response in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
    Gaut, Daria
    Sim, Myung Shin
    Yue, Yuguang
    Wolf, Brian R.
    Abarca, Phillip A.
    Carroll, James M.
    Goldman, Jonathan W.
    Garon, Edward B.
    CLINICAL LUNG CANCER, 2018, 19 (01) : E19 - E28
12345